Perturbations of peripheral B lymphocyte homoeostasis in children with systemic lupus erythematosus.
about
Correlation of circulating CD27high plasma cells and disease activity in systemic lupus erythematosusMyeloid cells limit production of antibody-secreting cells after immunization in the lymph node.Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations.Immunology of IgG4-related disease.Immunologic basis for revaccination of HIV-infected children receiving HAART.Early differentiated CD138(high) MHCII+ IgG+ plasma cells express CXCR3 and localize into inflamed kidneys of lupus miceDual B cell immunotherapy is superior to individual anti-CD20 depletion or BAFF blockade in murine models of spontaneous or accelerated lupus.Aberrant B-cell homeostasis in chronic GVHDLong-lived plasma cells are early and constantly generated in New Zealand Black/New Zealand White F1 mice and their therapeutic depletion requires a combined targeting of autoreactive plasma cells and their precursors.Mechanisms of B cell autoimmunity in SLE.Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjögren's syndrome and systemic lupus erythematosus.Analyses of CD27++ plasma cells in peripheral blood from patients with bacterial infections and patients with serum antinuclear antibodies.Plasmablast frequency and trafficking receptor expression are altered in pediatric ulcerative colitis.Alterations in peripheral blood memory B cells in patients with active rheumatoid arthritis are dependent on the action of tumour necrosis factorPeripheral B cell abnormalities and disease activity in systemic lupus erythematosus.Ligation of CD180 inhibits IFN-α signaling in a Lyn-PI3K-BTK-dependent manner in B cells.T cells that promote B-Cell maturation in systemic autoimmunityIndications for use and safety of rituximab in childhood renal diseases.Rationale of anti-CD19 immunotherapy: an option to target autoreactive plasma cells in autoimmunity.New insights into the pathogenesis and management of lupus in children.Update on B-cell targeted therapies for systemic lupus erythematosus.Current role of rituximab in systemic lupus erythematosus.[B-cell targeted therapy for children and adolescents with rheumatic diseases].A Novel Human Systemic Lupus Erythematosus Model in Humanised Mice.The ginsenoside metabolite compound K exerts its anti-inflammatory activity by downregulating memory B cell in adjuvant-induced arthritis.The human immunomodulatory CD25+ B cell population belongs to the memory B cell pool.Increased mutations of CD72 transcript in B-lymphocytes from adolescent patients with systemic lupus erythematosus.
P2860
Q28269798-D530648D-39F4-4456-B001-0560204E4DBCQ30574297-BCEAD8AC-8BC1-4104-AC19-D8D62A620946Q34419596-C02EDC0F-62B9-431C-BB7D-300495038153Q34471314-B546EE26-C8E7-4E08-B2F6-C59AAFC9047FQ34575987-9B50994D-CA99-47B0-BCAB-518337C98E9FQ34631749-138913EC-DB80-466C-ADFC-43E1E2AE6549Q35035048-057D4647-628F-446E-99B5-82066F4DE2D2Q35171251-EFB92FA1-52F3-4FAB-AFB4-BDAA9340BAADQ35544326-5D3D2984-1760-400F-97C2-5DEFC6D1BD11Q35840704-CCE0120E-703B-4E06-BBA6-6CCA26916A6AQ35953373-B57052CA-CDA0-4ABB-A7CE-56EB7FD780E9Q36087500-2BD46ED4-9FF6-4C08-9E7F-9A6C8F6EA66FQ36113666-08C84B83-B507-4696-885F-5A5A2399CF7BQ37270827-7DF2934C-96E2-4696-AEFD-5D32A86842AAQ37333433-859C976A-CA88-41AF-A8DF-0E66C1757A94Q37634933-A54F532D-5942-4046-9034-7CDD76603D31Q38002491-720F3294-592F-4D3E-969D-1B28CD854A4FQ38044851-8A066DE8-438E-4079-B797-5FB4D63591C3Q38071110-8503A383-1CB6-4D64-B91D-EA41CFF30CD1Q38192577-0BF85FE3-AFFC-49D1-9F2C-50B5392C2B1BQ38192656-AC1359BB-AE37-4ED5-A936-D47823873FADQ38293284-B2C5E9E6-0997-49F0-88D5-CAA738E5A7C5Q43687687-24A0181E-6BD2-47C8-95D5-F1BAAF6276EDQ47138126-141DEC18-048C-4F51-872B-5ABBAEA426B8Q50647527-FE2DDAE3-A2E0-4265-A8B0-65001398317DQ51974224-D3D36625-8F9C-4742-9632-DC49608948FDQ53587010-0E241268-47F7-4E9C-B9E0-69C74ED63019
P2860
Perturbations of peripheral B lymphocyte homoeostasis in children with systemic lupus erythematosus.
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Perturbations of peripheral B ...... systemic lupus erythematosus.
@ast
Perturbations of peripheral B ...... systemic lupus erythematosus.
@en
type
label
Perturbations of peripheral B ...... systemic lupus erythematosus.
@ast
Perturbations of peripheral B ...... systemic lupus erythematosus.
@en
prefLabel
Perturbations of peripheral B ...... systemic lupus erythematosus.
@ast
Perturbations of peripheral B ...... systemic lupus erythematosus.
@en
P2093
P2860
P356
P1476
Perturbations of peripheral B ...... systemic lupus erythematosus.
@en
P2093
Bunikowski R
Odendahl M
Radbruch A
P2860
P304
P356
10.1136/ARD.62.9.851
P407
P577
2003-09-01T00:00:00Z